PONESIMOD

438 reported adverse events

Drug classes: Sphingosine 1-phosphate Receptor Modulator [EPC]

These side effects are most commonly reported by patients taking PONESIMOD:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 76
1 FATIGUE 35
2 DIZZINESS 25
3 DYSPNOEA 24
4 HEADACHE 22
5 PRODUCT USE ISSUE 17
6 NAUSEA 14
7 COVID-19 13
8 DRUG INEFFECTIVE 13
9 PAIN 12
See all common reactions for PONESIMOD

PONESIMOD is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SI QIII TIII PATTERN 1 0.3333
1 LUNG INDURATION 1 0.0556
2 MYOPIC CHORIORETINAL DEGENERATION 1 0.0357
3 PAPILLARY RENAL CELL CARCINOMA 1 0.0074
4 BIRTH MARK 1 0.0048
5 GENITAL HERPES SIMPLEX 1 0.0047
6 DYSCALCULIA 1 0.0040
7 CERVIX CARCINOMA STAGE 0 1 0.0035
8 RELAPSING MULTIPLE SCLEROSIS 1 0.0033
9 NEUROMUSCULAR TOXICITY 1 0.0028
See all enriched reactions for PONESIMOD